FDA Inspection 1100779 — Lotus Clinical Research
The FDA completed an inspection of Lotus Clinical Research on June 21, 2019 in Pasadena, CA. The inspection was classified NAI (No Action Indicated — no objectionable conditions were found). Product area: Drugs.
Inspection Details
- Classification
- No Action Indicated (NAI) (NAI)
- End Date
- June 21, 2019
- Fiscal Year
- 2019
- Product Type
- Drugs
- Project Area
- Bioresearch Monitoring
- Location
- Pasadena, CA (United States)
Additional Details
Sponsor, Contract Research Organization